More on AGNPF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.25 |
|
|||
| Open | $0.27 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.27 | ||||
| Day Low | $0.27 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 29,018 | ||||
- Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa
- Algernon Health changes name to Grey Matters Health, implements 10:1 share consolidation
- Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation
- Algernon Health plans name change to Grey Matters Health, 10:1 share consolidation
- Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation
- Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers
- Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building
- Algernon Health raises $500,000 in private placement
- Algernon Health Announces Private Placement
- Algernon Pharmaceuticals changes name to Algernon Health
Entities mentioned with AGNPF
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- Earnings | View Related Stories »
- Maxim Group | View Related Stories »
- Bill & Melinda Gates Foundation Trust | View Related Stories »
- AdCom | View Related Stories »
- Hedge Funds | View Related Stories »
- Show More...
